Thursday's fiscal year-end report tests whether the turnaround sets a credible 2027 bar, or reveals what it...
Mounjaro, Zepbound, and a new oral pill are growing at once. The question is whether Foundayo's ramp...
Google's 20-year uprate deal shows the scarce asset is a plant already on the grid.
Q3 guidance is $5.55 to $5.65 per share vs. $2.63 a year ago. Is the run already...
Revenue more than doubled, margins expanded sharply, and S&P 500 index funds are now forced buyers, but...
A 27% intraday collapse and a near-50% China revenue drop preview what European carmakers face as they...
A Section 338 tariff lawsuit is the real variable for GM, Ford, and Stellantis.
With an October pause priced in and December still live, a Treasury ladder beats waiting for clarity...
ATI detected 5 times more geometry defects than visual inspections. The market is ignoring what that means...
The acquisition of Onnec repositions CBRE well beyond real estate services, but the deal size barely moves...